Trademark: 77580826
Word
INCRESYNC
Status
Dead
Status Code
606
Status Date
Monday, March 18, 2013
Serial Number
77580826
Mark Type
4000
Filing Date
Monday, September 29, 2008
Published for Opposition
Tuesday, March 17, 2009
Abandoned Date
Monday, March 18, 2013

Trademark Owner History
Takeda Pharmaceutial Company Limited - Owner At Publication

Classifications
5 Orally administered pharmaceutical preparations for the treatment and prevention of diabetic diseases, namely, type II diabetes, excluding preparations for the treatment of growth factor deficiency

Trademark Events
Mar 18, 2013
Abandonment Notice Mailed - No Use Statement Filed
Mar 18, 2013
Abandonment - No Use Statement Filed
Aug 23, 2012
Notice Of Approval Of Extension Request E-Mailed
Aug 22, 2012
Extension 2 Granted
Aug 7, 2012
Extension 2 Filed
Aug 20, 2012
Case Assigned To Intent To Use Paralegal
Aug 7, 2012
Teas Extension Received
Jan 27, 2012
Notice Of Approval Of Extension Request E-Mailed
Jan 25, 2012
Extension 1 Granted
Jan 25, 2012
Extension 1 Filed
Jan 25, 2012
Teas Extension Received
Aug 16, 2011
Noa E-Mailed - Sou Required From Applicant
Jul 1, 2011
Ttab Release Case To Trademarks
Jul 1, 2011
Opposition Terminated No. 999999
Jul 1, 2011
Opposition Dismissed No. 999999
Jun 6, 2011
Paper Received
Sep 14, 2009
Opposition Instituted No. 999999
Apr 9, 2009
Extension Of Time To Oppose Received
Mar 17, 2009
Published For Opposition
Feb 25, 2009
Notice Of Publication
Feb 10, 2009
Law Office Publication Review Completed
Feb 9, 2009
Approved For Pub - Principal Register
Feb 6, 2009
Assigned To Examiner
Jan 30, 2009
Teas/Email Correspondence Entered
Jan 30, 2009
Correspondence Received In Law Office
Jan 30, 2009
Assigned To Lie
Jan 23, 2009
Teas Response To Office Action Received
Dec 28, 2008
Notification Of Non-Final Action E-Mailed
Dec 28, 2008
Non-Final Action E-Mailed
Dec 28, 2008
Non-Final Action Written
Dec 28, 2008
Assigned To Examiner
Oct 3, 2008
Notice Of Pseudo Mark Mailed
Oct 2, 2008
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24